A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

Sharma, N.; Donnellan, C.; Preston, C.; Delaney, B.; Duckelt, G.; Moayyedi, P.
May 2004
Gut;May2004 Supplement 4, Vol. 53, piv58
Academic Journal
Symptoms are an important outcome for measurement in clinical trials into gastro-esophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.


Related Articles

  • Assessment of reflux symptom severity: methodological options and their attributes. Bytzer, P. // Gut;May2004 Supplement 4, Vol. 53, piv28 

    Despite major advances in our understanding of reflux disease, the management of this disorder still presents many challenges. Reduction of heartburn is the most readily apparent objective for the patient with reflux disease. Thus the ability to measure heartburn accurately is of fundamental...

  • Commentary: Randomised trials of surgical and non-surgical treatment: a role model for the future. Blazeby, Jane M.; Barham, C. Paul; Donovan, Jenny L. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/10/2009, p84 

    In this article the authors discuss research in clinical trials which has been conducted in an effort to determine the efficacy of surgery for the treatment of acid reflux and heartburn. They are critical of the methodology which is often used to conduct clinical trials. Also examined are the...

  • Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan. Ozawa, Soji; Kumai, Koichiro; Higuchi, Kazuhide; Arakawa, Tetsuo; Kato, Mototsugu; Asaka, Masahiro; Katada, Natsuya; Kuwano, Hiroyuki; Kitajima, Masaki // Journal of Gastroenterology;2009, Vol. 44 Issue 7, p675 

    Endoluminal gastroplication (ELGP) was the first endoscopic therapy for gastroesophageal reflux disease (GERD). Data on the long-term outcomes, including the plication status and data from Asian populations, are limited. The aim of this study was to evaluate the short-term and long-term...

  • Concomitant Symptoms Itemized in the Reflux Disease Questionnaire Are Associated With Attenuated Heartburn Response to Acid Suppression. Kahrilas, Peter J; Jonsson, Andreas; Denison, Hans; Wernersson, Börje; Hughes, Nesta; Howden, Colin W // American Journal of Gastroenterology;Sep2012, Vol. 107 Issue 9, p1354 

    OBJECTIVES:The Reflux Disease Questionnaire (RDQ) contains six symptom items for diagnosing and gauging gastroesophageal reflux disease (GERD) severity. However, clinical trials have generally focused only on the 'substernal burning' item and limited data exist on the effect of concomitant items...

  • Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Jones, Roger; Horbach, Silke; Sander, Peter; Rydén-Bergsten, Tina; Rydén-Bergsten, Tina // PharmacoEconomics;2003, Vol. 21 Issue 15, p1091 

    Background: Gastro-oesophageal reflux disease (GORD) is widespread in the general population and presents in most cases with heartburn as the main symptom. The severity of symptoms is not necessarily related to erosive damage to the oesophagus due to acid reflux, but the frequency...

  • A blueprint for symptom scales and responses: measurement and reporting. Wyrwich, K. W.; Tardino, V. M. Staebler // Gut;May2004 Supplement 4, Vol. 53, piv45 

    Measurement of symptom status among patients with GORD has, to date, been conducted in a variety of ways. We applied a cognitive psychology framework, as well as reviewed the current psychometric literature, to develop a blueprint for the best methods of measuring and reporting symptoms of...

  • Comparing Lansoprazole and Omeprazole in Onset of Heartburn Relief: Results of a Randomized, Controlled Trial in Erosive Esophagitis Patients. Richter, Joel E.; Kahrilas, Peter J.; Sontag, Stephen J.; Kovacs, Thomas O. G.; Bidan Huang; Pencyla, Jennifer L. // American Journal of Gastroenterology;Nov2001, Vol. 96 Issue 11, p3089 

    OBJECTIVE: This randomized, double-blind, multicenter study was conducted to confirm a previous finding that lansoprazole relieves heartburn faster than omeprazole in patients with erosive esophagitis. METHODS: A total of 3510 patients with erosive esophagitis and at least one episode of...

  • Late meal=more heartburn. Lee, Heather // Prevention;May2006, Vol. 58 Issue 5, p34 

    The article reports that a research study in Japan surveyed acid reflux patients and healthy individuals and found that those who ate within three hours before going to bed had a seven-times higher risk of suffering a bout of acid reflux or heartburn pain. The article advises not eating snacks...

  • Clinical Clips. Mintz, Matthew; Nicklin, David; Russell, John J. // Patient Care for the Nurse Practitioner;Jun2003, Vol. 6 Issue 6, p2 

    The article provides information on the results of several clinical trials. Investigators assesses the value of proton-pump inhibitor therapy with or without a prokinetic agent in the diagnosis and treatment of gastroesophageal reflux disease-related cough. A meta-analysis of 52 controlled...


Read the Article


Sign out of this library

Other Topics